Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Fish and Richardson
Teva
Federal Trade Commission
McKesson
Cantor Fitzgerald
US Department of Justice
Daiichi Sankyo
Colorcon

Generated: June 21, 2018

DrugPatentWatch Database Preview

BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Bacteriostatic Sodium Chloride 0.9% In Plastic Container patents expire, and what generic alternatives are available?

Bacteriostatic Sodium Chloride 0.9% In Plastic Container is a drug marketed by Abraxis Pharm, Fresenius Kabi Usa, and Hospira. and is included in three NDAs.

The generic ingredient in BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is sodium chloride. There are one thousand four hundred and twenty-six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the sodium chloride profile page.
Summary for BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Drug patent expirations by year for BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Pharmacology for BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

US Patents and Regulatory Information for BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 088909-001 Feb 7, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 088911-001 Feb 7, 1985 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 018800-001 Oct 29, 1982 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Cerilliant
UBS
Chinese Patent Office
Chubb
US Department of Justice
Cantor Fitzgerald
Colorcon
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.